As 2020 comes to a close, Zoom Video Communications Inc (NASDAQ: ZM) has already earned the title of one of the hottest tech stocks. The video communication company has seen demand surge nearly overnight as COVID-19 lockdowns forced companies to introduce new technologies so workers can communicate with each other.
But a vaccine against the novel coronavirus implies a return to some form of normalcy in the back half of 2021. As such, investors are wondering if Zoom’s exponential growth in 2020 will come to a sudden halt.
700% stock gain in 2020
Zoom’s stock is up a mind-boggling seven-fold in 2020 as the company transitioned from a fast-growing and niche tech company to a must-have product for both students and workers, according to CNBC.
The company’s sudden growth in March carried over throughout the year with no signs of slowing down. The company is scheduled to report third quarter results on Monday and analysts are expecting revenue to grow 317% year-over-year to $694 million. Even looking forward to the January-ending quarter, Zoom’s revenue growth rate is modeled to grow 288%, followed by 116% in the subsequent quarter, according to CNBC.
Here is a summary of Zoom’s second quarter earnings report and its first quarter report.
Analyst: the ‘wow’ factor coming to an end
Wall Street research firm Elazar Advisors said in November that Zoom benefited from a “wow” factor but the inevitable vaccine release means “there’s going to be perceptual headwinds” for the stock, according to CNBC.
Naturally, Zoom’s value proposition and sense of urgency will come to an end. There may not be much the company can even do after a 700% surge
